drugset / Trial / NCT03647423
QUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma.
RandomizedParallel-groupOpen-labelTreatment
Summary
QUILT 3.091 Chordoma Vaccine: Phase 1B/2 NANT Chordoma Vaccine vs Radiation in Subjects with Unresectable Chordoma.
Timeline
- Start
- 2018-08-31
- Primary completion
- 2020-08-31
- Completion
- 2021-12-28
Outcome
Outcome not reported
Stopped: “Trial not initiated”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aldoxorubicin | Small molecule | — | — |
| Subject | Avelumab | Monoclonal antibody | — | — |
| Subject | Cetuximab | Monoclonal antibody | — | — |
| Subject | Cyclophosphamide | Other / unclassified | — | — |
| Subject | ETBX-051 | Vaccine | — | — |
| Subject | ETBX-061 | Vaccine | — | — |
| Subject | GI-6301 | Vaccine | — | — |
| Subject | N-803 | Protein / enzyme biologic | — | — |
| Subject | haNK | Cell therapy | — | — |